BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36897074)

  • 21. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells.
    Veeraraghavan J; Natarajan M; Lagisetty P; Awasthi V; Herman TS; Aravindan N
    Pancreas; 2011 Oct; 40(7):1107-19. PubMed ID: 21697760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin and trans-resveratrol exert cell cycle-dependent radioprotective or radiosensitizing effects as elucidated by the PCC and G2-assay.
    Sebastià N; Montoro A; Hervás D; Pantelias G; Hatzi VI; Soriano JM; Villaescusa JI; Terzoudi GI
    Mutat Res; 2014; 766-767():49-55. PubMed ID: 25847272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status.
    Hesari A; Azizian M; Sheikhi A; Nesaei A; Sanaei S; Mahinparvar N; Derakhshani M; Hedayt P; Ghasemi F; Mirzaei H
    Int J Cancer; 2019 Mar; 144(6):1215-1226. PubMed ID: 30362511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SR 4233: a tumor specific radiosensitizer active in fractionated radiation regimes.
    Brown JM; Lemmon MJ
    Radiother Oncol; 1991; 20 Suppl 1():151-6. PubMed ID: 2020764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin as a great contributor for the treatment and mitigation of colorectal cancer.
    Karthika C; Hari B; Mano V; Radhakrishnan A; Janani SK; Akter R; Kaushik D; Rahman MH
    Exp Gerontol; 2021 Sep; 152():111438. PubMed ID: 34098006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosensitizing Potential of Curcumin in Different Cancer Models.
    Sak K
    Nutr Cancer; 2020; 72(8):1276-1289. PubMed ID: 31648572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facile green synthesis of bismuth sulfide radiosensitizer
    Nosrati H; Abhari F; Charmi J; Rahmati M; Johari B; Azizi S; Rezaeejam H; Danafar H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3832-3838. PubMed ID: 31556316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53.
    Xu R; Li H; Wu S; Qu J; Yuan H; Zhou Y; Lu Q
    Int Urol Nephrol; 2019 Oct; 51(10):1771-1779. PubMed ID: 31236854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-cancer effects of curcumin on head and neck cancers.
    Gao W; Chan JY; Wei WI; Wong TS
    Anticancer Agents Med Chem; 2012 Nov; 12(9):1110-6. PubMed ID: 22583425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-art.
    Zangui M; Atkin SL; Majeed M; Sahebkar A
    Pharmacol Res; 2019 Mar; 141():343-356. PubMed ID: 30641277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RRx-001, A novel dinitroazetidine radiosensitizer.
    Oronsky B; Scicinski J; Ning S; Peehl D; Oronsky A; Cabrales P; Bednarski M; Knox S
    Invest New Drugs; 2016 Jun; 34(3):371-7. PubMed ID: 26841903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications.
    Bar-Sela G; Epelbaum R; Schaffer M
    Curr Med Chem; 2010; 17(3):190-7. PubMed ID: 20214562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bortezomib-enhanced radiosensitization through the suppression of radiation-induced nuclear factor-κB activity in human oral cancer cells.
    Tamatani T; Takamaru N; Hara K; Kinouchi M; Kuribayashi N; Ohe G; Uchida D; Fujisawa K; Nagai H; Miyamoto Y
    Int J Oncol; 2013 Mar; 42(3):935-44. PubMed ID: 23340716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved synergic therapeutic effects of chemoradiation therapy with the aid of a co-drug-loaded nano-radiosensitizer under conventional-dose X-ray irradiation.
    Nosrati H; Charmi J; Abhari F; Attari E; Bochani S; Johari B; Rezaeejam H; Kheiri Manjili H; Davaran S; Danafar H
    Biomater Sci; 2020 Aug; 8(15):4275-4286. PubMed ID: 32589170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.
    Wilken R; Veena MS; Wang MB; Srivatsan ES
    Mol Cancer; 2011 Feb; 10():12. PubMed ID: 21299897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of Enhancing Effects of Curcumin on Radiotherapy with F98/
    Wang WH; Shen CY; Chien YC; Chang WS; Tsai CW; Lin YH; Hwang JJ
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells.
    Ghashghaei M; Niazi TM; Heravi M; Bekerat H; Trifiro M; Paliouras M; Muanza T
    Prostate; 2018 Jan; 78(1):64-75. PubMed ID: 29134684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3.
    Chendil D; Ranga RS; Meigooni D; Sathishkumar S; Ahmed MM
    Oncogene; 2004 Feb; 23(8):1599-607. PubMed ID: 14985701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin: a new radio-sensitizer of squamous cell carcinoma cells.
    Khafif A; Hurst R; Kyker K; Fliss DM; Gil Z; Medina JE
    Otolaryngol Head Neck Surg; 2005 Feb; 132(2):317-21. PubMed ID: 15692547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gemcitabine and ionizing radiations: radiosensitization or radio-chemotherapy combination].
    Azria D; Jacot W; Prost P; Culine S; Ychou M; Lemanski C; Dubois JB
    Bull Cancer; 2002 Apr; 89(4):369-79. PubMed ID: 12016038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.